HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hidenori Yamasue Selected Research

Sarin

12/2009Smaller amygdala volume and reduced anterior cingulate gray matter density associated with history of post-traumatic stress disorder.
1/2007Human brain structural change related to acute single exposure to sarin.
4/2006Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism.
6/2005Support for relationship between serum cholinesterase and post-traumatic stress disorder; 5-year follow-ups of victims of the Tokyo subway sarin poisoning.
3/2005Association between lower P300 amplitude and smaller anterior cingulate cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack.
9/2003Hypoactivation of the prefrontal cortex during verbal fluency test in PTSD: a near-infrared spectroscopy study.
7/2003Activation of the prefrontal cortex to trauma-related stimuli measured by near-infrared spectroscopy in posttraumatic stress disorder due to terrorism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hidenori Yamasue Research Topics

Disease

12Schizophrenia (Dementia Praecox)
09/2014 - 12/2003
6Autistic Disorder (Autism)
11/2015 - 04/2009
6Post-Traumatic Stress Disorders (PTSD)
12/2009 - 07/2003
4Pervasive Child Development Disorders
11/2015 - 04/2009
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
11/2015 - 11/2015
1Hallucinations (Hallucination)
11/2011
1Bipolar Disorder (Mania)
08/2011
1Hypercalcemia (Milk Alkali Syndrome)
08/2011
1Metabolic Brain Diseases (Encephalopathy, Metabolic)
12/2010
1Epilepsy (Aura)
12/2010
1Citrullinemia
12/2010
1Obstructive Sleep Apnea
12/2010
1Dyskinesias (Dyskinesia)
12/2010
1Seizures (Seizure)
12/2010
1Mood Disorders (Mood Disorder)
05/2010
1Neurobehavioral Manifestations
01/2007
1Poisoning
06/2005
1Parkinsonian Disorders (Parkinsonism)
12/2003
1Wounds and Injuries (Trauma)
07/2003

Drug/Important Bio-Agent (IBA)

7SarinIBA
12/2009 - 07/2003
6Oxytocin (Pitocin)FDA LinkGeneric
11/2015 - 04/2009
2Methylphenidate (Ritalin)FDA LinkGeneric
11/2015 - 11/2015
2Methamphetamine (Desoxyn)FDA LinkGeneric
07/2013 - 11/2011
2Temazepam (Nocturne)FDA LinkGeneric
09/2007 - 06/2004
2Hemoglobins (Hemoglobin)IBA
09/2003 - 07/2003
1Oxytocin Receptors (Oxytocin Receptor)IBA
10/2014
1Glutamic Acid (Glutamate)FDA Link
09/2014
1N-acetylaspartate (N-acetyl aspartate)IBA
09/2014
1Glutamine (L-Glutamine)FDA Link
09/2014
1Protons (Proton)IBA
09/2014
1Biological Markers (Surrogate Marker)IBA
01/2013
11-hydroxycholecalciferol (alfacalcidol)IBA
08/2011
1Serotonin (5 Hydroxytryptamine)IBA
05/2010
1metabotropic glutamate receptor 3 (mGluR3)IBA
12/2006
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2006
1perospironeIBA
03/2006
1Serotonin 5-HT1 Receptor AgonistsIBA
03/2006
1Serotonin 5-HT2 Receptor AntagonistsIBA
03/2006
1Cholinesterases (Cholinesterase)IBA
06/2005
1acceleratory factor from growth hormone (AcG)IBA
09/2004
1Antipsychotic Agents (Antipsychotics)IBA
12/2003
1Choline (Choline Chloride)IBA
12/2003

Therapy/Procedure

2Intranasal Administration
11/2015 - 11/2014
1Nebulizers and Vaporizers (Inhaler)
07/2015
1Liver Transplantation
12/2010
1Continuous Positive Airway Pressure
12/2010